Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · IEX Real-Time Price · USD
7.85
+0.10 (1.29%)
At close: Jul 19, 2024, 4:00 PM
7.79
-0.06 (-0.83%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 267 employees as of December 31, 2023. The number of employees decreased by 7 or -2.55% compared to the previous year.
Employees
267
Change (1Y)
-7
Growth (1Y)
-2.55%
Revenue / Employee
$224,127
Profits / Employee
-$431,708
Market Cap
1.22B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Omnicell | 3,650 |
Artivion | 1,500 |
AtriCure | 1,050 |
Establishment Labs Holdings | 908 |
Maravai LifeSciences Holdings | 650 |
Sana Biotechnology | 328 |
Relay Therapeutics | 323 |
Xencor | 280 |
OCUL News
- 3 days ago - Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Ocular Therapeutix™ Announces Late-Breaking Abstract of HELIOS Study to be Presented at 42nd ASRS Annual Scientific Meeting - GlobeNewsWire
- 13 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
- 5 weeks ago - Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study - GlobeNewsWire
- 6 weeks ago - Ocular Therapeutix® to Host Investor Day on June 13, 2024 - GlobeNewsWire
- 6 weeks ago - Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Ocular Therapeutix™ Reports First Quarter 2024 Results - GlobeNewsWire